Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Lotus Ventures Inc. LTTSF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
22/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lotus Ventures Inc. (LTTSF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 20/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $2M, -10.8%/yr average growth. Net income is $2M (loss), growing at -706.6%/yr. Net profit margin is -93.7% (negative). Gross margin is -6.9% (-87.1 pp trend).

Balance sheet: total debt is $2M against $9M equity (Debt-to-Equity (D/E) ratio 0.27, conservative). Current ratio is 0.36 (tight liquidity). Debt-to-assets is 17.5%. Total assets: $14M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 50/100 (Partial), Health 33/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

LTTSF SharesGrow Score Overview

27/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — LTTSF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
LTTSF: -10.8%/yr revenue is, -706.6%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
LTTSF: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
33/100
Balance sheet LTTSF: Debt-to-Equity (D/E) ratio 0.27 (conservative), Current ratio is 0.36 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
LTTSF: Net profit margin is -93.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0041-0.0525
Volume105
Avg Volume (30D)111
Market Cap$458.85K
Beta (1Y)-0.32
Share Statistics
EPS (TTM)-0.02
Shares Outstanding$89.97M
IPO Date2018-09-11
CEODale Bernard McClanaghan MBA
Financial Highlights & Ratios
Revenue (TTM)$2M
Gross Profit$-137.15K
EBITDA$-969.44K
Net Income$-1.87M
Operating Income$-1.59M
Total Cash$44.74K
Total Debt$2.43M
Net Debt$2.39M
Total Assets$13.89M
Price / Earnings (P/E)-0.2
Price / Sales (P/S)0.23
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA54571Q1081

Price Chart

Track all markets on TradingView
LTTSF
Lotus Ventures Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.05

People Also View

RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 PHCG
PHCG
Pure Harvest Corporate Group, Inc.
$0.01
+4.00%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-4.57%
 SPBBF
SPBBF
Speakeasy Cannabis Club Ltd.
$0.00
+0.00%
 RVVQF
RVVQF
RavenQuest BioMed Inc.
$0.00
+0.00%
 BHHKF
BHHKF
Craftport Cannabis Corp.
$0.00
+0.00%
 CRFTF
CRFTF
BC Craft Supply Co. Ltd.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message